• Blog
  • Pricing
  • Contact
  • FAQ
Sign InSign Up
AI Agent for Financial MarketsAsk anything. Our AI Agent brings real-time data and full market coverage.Open chat
MarketsStocksCryptoForexCommoditiesCalendarInsiders
TELA

TELA

TELA Bio, Inc.

NASDAQHealthcareMedical - DevicesUS

USD0.86

-0.05 (-5.49%)

Rating:B-

Company Profile

CEO

Antony Koblish

IPO Date

2019-11-08

Sector

Healthcare

Industry

Medical - Devices

Exchange

NASDAQ

Country

US

Market Metrics

Open

$0.90

Prev. Close

$0.91

Day Low

$0.86

Day High

$0.97

52W Low

$0.50

52W High

$2.20

Market Cap

$0.04B

Volume

0.14M

OverviewFinancialsRatingsInsidersSentimentsChart Patterns
News SentimentBullish

Articles

10

Avg Positive

23.6%

Avg Negative

2.7%

Avg Neutral

73.7%

News Feed

New Strong Sell Stocks for June 18th

Zacks Investment Research·6/18/2021·↑ positive

TELA Bio to Participate in Upcoming JMP Securities Life Sciences Conference

GlobeNewsWire·6/14/2021·↑ positive

TELA Bio to Participate in Upcoming Investor Conferences

GlobeNewsWire·5/21/2021·↑ positive

TELA Bio Launches Post Market Study Of OviTex In Hernia Surgery

Benzinga·5/19/2021·↑ positive

TELA Bio Initiates BRAVO II Study of OviTex® for the Robotic Repair of Ventral Hernias

GlobeNewsWire·5/19/2021·↑ positive

TELA Bio Inc. (TELA) CEO Tony Koblish on Q1 2021 Results - Earnings Call Transcript

Seeking Alpha·5/14/2021·↓ negative

TELA Bio, Inc. (TELA) Reports Q1 Loss, Tops Revenue Estimates

Zacks Investment Research·5/13/2021·↓ negative

TELA Bio: Q1 Earnings Insights

Benzinga·5/13/2021·↑ positive

TELA Bio Announces First Quarter 2021 Financial Results

GlobeNewsWire·5/13/2021·↑ positive

TELA Bio to Announce First Quarter 2021 Financial Results

GlobeNewsWire·4/29/2021·↑ positive